Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to PRIAS criteria.

Abstract

Notwithstanding the PRIAS criteria can identify some PCa patients as low-risk, at pathological evaluation some of them harbored intermediate- or high-risk disease. According to our data, patients eligible for AS should be carefully counseled about possible disease understaging.